The CDKN2A/B rs10811661 polymorphism is associated with metabolic syndrome, insulin resistance, and lipid levels in individuals with obesity and impaired fasting glucoseon January 25, 2026 at 2:32 pm
Publication date: Available online 24 January 2026 Source: Clinical Biochemistry Author(s): Daniel de Luis, Olatz Izaola, David Primo